[{"address1": "1035 Cambridge Street", "address2": "Suite 18A", "city": "Cambridge", "state": "MA", "zip": "02141", "country": "United States", "phone": "212 582 1199", "website": "https://www.ernexatx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Ms. Sandra M. Gurrola", "age": 58, "title": "Principal Financial & Accounting Officer and Senior VP of Finance", "yearBorn": 1967, "fiscalYear": 2025, "totalPay": 286000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kanika  Chawla Ph.D.", "title": "Senior Vice President of Technical Operations (Consultant)", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.68, "open": 0.4, "dayLow": 0.3105, "dayHigh": 0.4183, "regularMarketPreviousClose": 0.68, "regularMarketOpen": 0.4, "regularMarketDayLow": 0.3105, "regularMarketDayHigh": 0.4183, "payoutRatio": 0.0, "beta": 6.737, "trailingPE": 0.006681463, "forwardPE": -0.039197914, "volume": 3844529, "regularMarketVolume": 3844529, "averageVolume": 146468, "averageVolume10days": 87870, "averageDailyVolume10Day": 87870, "bid": 0.3398, "ask": 0.4125, "bidSize": 1, "askSize": 1, "marketCap": 2955286, "fiftyTwoWeekLow": 0.3105, "fiftyTwoWeekHigh": 5.55, "allTimeHigh": 345000.0, "allTimeLow": 0.67, "priceToSalesTrailing12Months": 2955.286, "fiftyDayAverage": 1.2326, "twoHundredDayAverage": 1.77985, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 459536, "profitMargins": 0.0, "floatShares": 2408432, "sharesOutstanding": 7853538, "sharesShort": 138506, "sharesShortPriorMonth": 118475, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0176, "heldPercentInsiders": 0.66064, "heldPercentInstitutions": 0.069180004, "shortRatio": 0.8, "shortPercentOfFloat": 0.0215, "impliedSharesOutstanding": 7853538, "bookValue": 0.455, "priceToBook": 0.827033, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -18357000, "trailingEps": 56.32, "forwardEps": -9.6, "lastSplitFactor": "1:15", "lastSplitDate": 1749686400, "enterpriseToRevenue": 459.537, "enterpriseToEbitda": -0.047, "52WeekChange": -0.85833335, "SandP52WeekChange": 0.120657206, "quoteType": "EQUITY", "currentPrice": 0.3763, "recommendationKey": "none", "totalCash": 3047000, "totalCashPerShare": 0.388, "ebitda": -9851000, "totalDebt": 552000, "quickRatio": 1.493, "currentRatio": 1.576, "totalRevenue": 1000, "debtToEquity": 15.462, "revenuePerShare": 0.0, "returnOnAssets": -0.89291, "grossProfits": 1000, "freeCashflow": -6207125, "operatingCashflow": -9414000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -9922.0, "financialCurrency": "USD", "symbol": "ERNA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_24349026", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -44.6618, "regularMarketPrice": 0.3763, "longName": "Ernexa Therapeutics Inc.", "fiftyDayAverageChange": -0.8563, "fiftyDayAverageChangePercent": -0.6947104, "twoHundredDayAverageChange": -1.40355, "twoHundredDayAverageChangePercent": -0.7885777, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "NTN Buzztime, Inc", "nameChangeDate": "2026-02-06", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 683472600000, "marketState": "CLOSED", "postMarketChangePercent": -3.1358013, "postMarketPrice": 0.3645, "postMarketChange": -0.011800021, "regularMarketChange": -0.3037, "regularMarketDayRange": "0.3105 - 0.4183", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 146468, "fiftyTwoWeekLowChange": 0.06580001, "fiftyTwoWeekLowChangePercent": 0.2119163, "fiftyTwoWeekRange": "0.3105 - 5.55", "fiftyTwoWeekHighChange": -5.1737003, "fiftyTwoWeekHighChangePercent": -0.9321982, "fiftyTwoWeekChangePercent": -85.833336, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 56.32, "epsForward": -9.6, "shortName": "Ernexa Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1770425873, "regularMarketTime": 1770411602, "displayName": "Ernexa Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]